Literature DB >> 24803072

Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Amir Kol1, Soraya Foutouhi, Naomi J Walker, Nguyet T Kong, Bart C Weimer, Dori L Borjesson.   

Abstract

Mesenchymal stem cells (MSCs) are somatic, multipotent stromal cells with potent immunomodulatory and regenerative properties. Although MSCs have pattern recognition receptors and are modulated by Toll-like receptor ligands, MSC-microbial interactions are poorly defined. The objectives of this study were to determine the effect of bacterial association on MSC function. We hypothesized that gastrointestinal bacteria associate with MSCs and alter their immunomodulatory properties. The effect of MSC-microbial interactions on MSC morphology, viability, proliferation, migration, and immunomodulatory functions was investigated. MSCs associated with a remarkable array of enteric pathogens and commensal bacteria. MSC interactions with two model organisms, the pathogen Salmonella typhimurium and the probiotic Lactobacillus acidophilus, were further investigated. While ST readily invaded MSCs, LB adhered to the MSC plasma membrane. Neither microbe induced MSC death, degeneration, or diminished proliferation. Microbial association did not upregulate MHC-II, CD80/86, or CD1 expression. MSC-microbial interaction significantly increased transcription of key immunomodulatory genes, including COX2, IL6, and IL8, coupled with significantly increased prostaglandin E2 (PGE2), interleukin (IL)6, and IL8 secretion. MSC-ST coincubation resulted in increased MSC expression of CD54, and significant augmentation of MSC inhibition of mitogen-induced T-cell proliferation. T-cell proliferation was partially restored when PGE2 secretion was blocked from ST-primed MSCs. MSC-microbe interactions have a profound effect on MSC function and may be pivotal in a variety of clinical settings where MSCs are being explored as potential therapeutics in the context of microbial communities, such as Crohn's disease, chronic nonhealing wounds, and sepsis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24803072      PMCID: PMC4120524          DOI: 10.1089/scd.2014.0128

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  67 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Authors:  Gordana Raicevic; Mehdi Najar; Karlien Pieters; Cecile De Bruyn; Nathalie Meuleman; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Tissue Eng Part A       Date:  2012-04-25       Impact factor: 3.845

3.  Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Authors:  Anna Krasnodembskaya; Gianluca Samarani; Yuanlin Song; Hanjing Zhuo; Xiao Su; Jae-Woo Lee; Naveen Gupta; Mario Petrini; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

Review 4.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

5.  Host cell responses of Salmonella typhimurium infected human dendritic cells.

Authors:  Stephen Gitahi Kiama; Donatus Dreher; Laurence Cochand; Menno Kok; Carolina Obregon; Laurent Nicod; Peter Gehr
Journal:  Immunol Cell Biol       Date:  2006-07-20       Impact factor: 5.126

6.  Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.

Authors:  Xiao-Wen He; Xiao-Sheng He; Lei Lian; Xiao-Jian Wu; Ping Lan
Journal:  Dig Dis Sci       Date:  2012-06-30       Impact factor: 3.199

Review 7.  Systemic antibody responses to gut microbes in health and disease.

Authors:  Kathrin Zimmermann; Anna Haas; Annette Oxenius
Journal:  Gut Microbes       Date:  2012-01-01

8.  Duplex real-time SYBR green PCR assays for detection of 17 species of food- or waterborne pathogens in stools.

Authors:  Hiroshi Fukushima; Yoshie Tsunomori; Ryotaro Seki
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Apoptosis of human intestinal epithelial cells after bacterial invasion.

Authors:  J M Kim; L Eckmann; T C Savidge; D C Lowe; T Witthöft; M F Kagnoff
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  Increased expression of interleukin-1beta and its novel splice variant in canine hearts with volume overload.

Authors:  Liliana Kiczak; Urszula Paslawska; Jacek Bania; Maciej Ugorski; Izabela Sambor; Agata Kochman; Joanna Blach; Anna Chelmonska-Soyta
Journal:  Cytokine       Date:  2008-11-12       Impact factor: 3.861

View more
  31 in total

Review 1.  Targeting Stem Cells in Chronic Inflammatory Diseases.

Authors:  Mari van de Vyver; Carine Smith; Yigael S L Powrie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development.

Authors:  Boaz Arzi; Amir Kol; Brian Murphy; Naomi J Walker; Joshua A Wood; Kaitlin Clark; Frank J M Verstraete; Dori L Borjesson
Journal:  Stem Cells Dev       Date:  2014-12-31       Impact factor: 3.272

3.  Human Adipose Tissue-Derived Stromal Cells Attenuate the Multiple Organ Injuries Induced by Sepsis and Mechanical Ventilation in Mice.

Authors:  Shuya Mei; Shuang Wang; Shuqing Jin; Xiang Zhao; Zhenzhen Shao; Renlingzi Zhang; Xiangsheng Yu; Yao Tong; Shibiao Chen; Zhixia Chen; Quan Li
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

4.  Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.

Authors:  William H Wheat; Lyndah Chow; Jade N Kurihara; Daniel P Regan; Jonathan W Coy; Tracy L Webb; Steven W Dow
Journal:  Stem Cells Dev       Date:  2016-12-22       Impact factor: 3.272

Review 5.  Mesenchymal stem cells as a therapeutic tool to treat sepsis.

Authors:  Eleuterio Lombardo; Tom van der Poll; Olga DelaRosa; Wilfried Dalemans
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

6.  Are Adipose-Derived Stem Cells From Liver Falciform Ligaments Another Possible Source of Mesenchymal Stem Cells?

Authors:  Sang Woo Lee; Jae Uk Chong; Seon Ok Min; Seon Young Bak; Kyung Sik Kim
Journal:  Cell Transplant       Date:  2016-11-24       Impact factor: 4.064

Review 7.  Do oral bacteria alter the regenerative potential of stem cells? A concise review.

Authors:  Kyriaki Chatzivasileiou; Katja Kriebel; Gustav Steinhoff; Bernd Kreikemeyer; Hermann Lang
Journal:  J Cell Mol Med       Date:  2015-06-08       Impact factor: 5.310

Review 8.  Are mesenchymal stromal cells immune cells?

Authors:  Martin J Hoogduijn
Journal:  Arthritis Res Ther       Date:  2015-03-31       Impact factor: 5.156

9.  Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.

Authors:  Kaitlin C Clark; Amir Kol; Salpi Shahbenderian; Jennifer L Granick; Naomi J Walker; Dori L Borjesson
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

10.  Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

Authors:  Boaz Arzi; Emily Mills-Ko; Frank J M Verstraete; Amir Kol; Naomi J Walker; Megan R Badgley; Nasim Fazel; William J Murphy; Natalia Vapniarsky; Dori L Borjesson
Journal:  Stem Cells Transl Med       Date:  2015-11-18       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.